Alerts will be sent to your verified email
Verify Email
AUROLAB
|
Auro Laboratories
|
Oxygenta Pharma
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.83 % | 15.02 % | -335.15 % |
|
5yr average Equity Multiplier
|
1.84 | -1.71 | 66.02 |
|
5yr Average Asset Turnover Ratio
|
0.8 | 1.26 | 1.14 |
|
5yr Avg Net Profit Margin
|
9.49 % | -10.07 % | -0.67 % |
|
Price to Book
|
4.18 | 0.0 | 16.31 |
|
P/E
|
61.51 | 0.0 | 19.66 |
|
5yr Avg Cash Conversion Cycle
|
80.24 Days | -21.7 Days | -33.97 Days |
|
Inventory Days
|
56.39 Days | 80.38 Days | 101.63 Days |
|
Days Receivable
|
214.37 Days | 20.8 Days | 98.68 Days |
|
Days Payable
|
115.48 Days | 154.17 Days | 171.28 Days |
|
5yr Average Interest Coverage Ratio
|
10.53 | -3.16 | 0.78 |
|
5yr Avg ROCE
|
16.02 % | -3.19 % | 10.6 % |
|
5yr Avg Operating Profit Margin
|
15.11 % | -9.3 % | 3.89 % |
|
5 yr average Debt to Equity
|
0.48 | -1.91 | 29.85 |
|
5yr CAGR Net Profit
|
-23.84 % | n/a | 13.51 % |
|
5yr Average Return on Assets
|
7.53 % | -6.87 % | -0.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.18 % | 55.93 % | 74.94 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.09 % | 43.6 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.04 % | 0.0 |
|
Auro Laboratories
|
Oxygenta Pharma
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|